Matrifen® with less fentanyl still eases severe chronic pain

The Matrifen® patch from Nycomed with less fentanyl still provides pain relief for patients with chronic pain such as cancer pain and low back pain.

The fentanyl patch Matrifen® provides excelent relief in patients with severe chronic pain.

>> Information on Matrifen® with less fentanyl

The transdermal patch Matrifen® with less fentanyl than in other products releases fentanyl over a 72 hour period for fast and effective relief of pains such as cancer pain, low back pain, naturopathic pain, nociceptive pain and other chronic pains.

The transdermal patch with less fentanyl has been shown to have fewer side effects compared to morphine tablets and other oral formulations of opiod analgesics.

The efficient and advanced fentanyl patch technology provides pain relief for cancer related as well as non cancer related pains and the lower drug load adds to a higher degree of safety and lower environmental burden.

About Nycomed
Nycomed is driving a new way of providing pharmaceutical products in Europe. Physicians are seeking new treatments that make a clear medical difference. But traditional pharmaceutical companies, with a single research department, are finding it harder to meet this need.

Nycomed, by contrast, can access the work of thousands of companies dedicated to research, and choose to make available the most innovative treatments.

Transdermal | Opioid effects | Silicone adhesion layer